Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesús Troya

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 17, 2018
Alternative switching strategies based on regimens with a low genetic barrier: do clinicians have a choice nowadays?Jesús Troya, Pablo Ryan, Rocío Montejano, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2025
Long-acting cabotegravir and rilpivirine for the treatment of people with HIV: current landscape and challenges aheadLuis Buzón-Martín, Alfonso Cabello, Alberto Díaz de Santiago, et al.
AIDS Care|September 6, 2021
Effectiveness of an HIV care model integrated into addiction care based on medication-assisted treatment for HIV-positive people who use drugsJorge Valencia, Jesús Troya, Jeffrey V Lazarus, et al.
Gastroenterologia Y Hepatologia|June 4, 2011
[Granular cell tumor of the esophagus: description of an infrequent benign tumor]Antonio Díaz-Sánchez, Susana Soto, Angel Ponferrada, et al.
Journal of Thrombosis and Thrombolysis|July 11, 2020
Aortic thrombus in patients with severe COVID-19: review of three casesMaría de Carranza, Danilo-Eduardo Salazar, Jesús Troya, et al.
Open Forum Infectious Diseases|July 12, 2021
Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, SpainJorge Valencia, Jesús Troya, Jeffrey V Lazarus, et al.
Plos One|April 1, 2020
Gender-based vulnerability in women who inject drugs in a harm reduction settingJorge Valencia, Alejandro Alvaro-Meca, Jesús Troya, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 22, 2025
Artificial intelligence in neuro-oncology: methodological bases, practical applications and ethical and regulatory issuesPedro David Delgado-López, Miguel Cárdenas Montes, Jesús Troya García, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|September 18, 2009
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcomeDavid Townsend, Jesús Troya, Ivana Maida, et al.
The International Journal on Drug Policy|June 30, 2019
High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction unitsJorge Valencia, Alejandro Alvaro-Meca, Jesús Troya, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 17, 2018
Alternative switching strategies based on regimens with a low genetic barrier: do clinicians have a choice nowadays?Jesús Troya, Pablo Ryan, Rocío Montejano, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2025
Long-acting cabotegravir and rilpivirine for the treatment of people with HIV: current landscape and challenges aheadLuis Buzón-Martín, Alfonso Cabello, Alberto Díaz de Santiago, et al.
AIDS Care|September 6, 2021
Effectiveness of an HIV care model integrated into addiction care based on medication-assisted treatment for HIV-positive people who use drugsJorge Valencia, Jesús Troya, Jeffrey V Lazarus, et al.
Gastroenterologia Y Hepatologia|June 4, 2011
[Granular cell tumor of the esophagus: description of an infrequent benign tumor]Antonio Díaz-Sánchez, Susana Soto, Angel Ponferrada, et al.
Journal of Thrombosis and Thrombolysis|July 11, 2020
Aortic thrombus in patients with severe COVID-19: review of three casesMaría de Carranza, Danilo-Eduardo Salazar, Jesús Troya, et al.
Open Forum Infectious Diseases|July 12, 2021
Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, SpainJorge Valencia, Jesús Troya, Jeffrey V Lazarus, et al.
Plos One|April 1, 2020
Gender-based vulnerability in women who inject drugs in a harm reduction settingJorge Valencia, Alejandro Alvaro-Meca, Jesús Troya, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 22, 2025
Artificial intelligence in neuro-oncology: methodological bases, practical applications and ethical and regulatory issuesPedro David Delgado-López, Miguel Cárdenas Montes, Jesús Troya García, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|September 18, 2009
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcomeDavid Townsend, Jesús Troya, Ivana Maida, et al.
The International Journal on Drug Policy|June 30, 2019
High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction unitsJorge Valencia, Alejandro Alvaro-Meca, Jesús Troya, et al.
Pageof 6